Royalty Pharma plc (RPRX) Earnings Per Share (EPS)
Royalty Pharma plc (RPRX) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2020-12-31 | $1.32 |
| 2021-12-31 | $1.49 |
| 2022-12-31 | $0.10 |
| 2023-12-31 | $2.54 |
| 2024-12-31 | $1.92 |
| 2025-12-31 | $1.79 |
How RPRX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| TGTX | TG Therapeutics Inc. | $2.77 |
| PFE | Pfizer Inc. | $1.36 |
| VCEL | Vericel Corporation | $0.32 |
| AKBA | Akebia Therapeutics Inc. | -$0.02 |
| TXMD | TherapeuticsMD Inc. | -$0.05 |
These are five companies in the same sector as RPRX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Royalty Pharma plc Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("RPRX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RPRX | $63.96 | +0.13% | 3.40M |
| 3 | ||||
| 4 | ||||
| 5 |